The PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects
Author Information
Author(s): Spinelli S. L., O'Brien J. J., Bancos S., Lehmann G. M., Springer D. L., Blumberg N., Francis C. W., Taubman M. B., Phipps R. P.
Primary Institution: University of Rochester Medical Center
Hypothesis
Understanding the biologic importance of platelet PPARs and the mechanisms by which PPARs regulate platelet activation will be imperative in designing therapeutic strategies.
Conclusion
Platelet-derived PPARs play an important role in controlling the magnitude of a platelet-driven inflammatory response, which can be targeted for drug development to combat cardiovascular diseases.
Supporting Evidence
- Platelets are key mediators of inflammation and immune cell activation.
- PPARs play a major role in modulating inflammation.
- Activated platelets release proinflammatory mediators that contribute to cardiovascular disease progression.
- PPAR agonists can attenuate platelet activation.
- Platelet-derived PPARs may help in the treatment of cardiovascular diseases.
Takeaway
Platelets are not just for blood clotting; they also help with inflammation, and special proteins called PPARs in platelets can help reduce heart disease.
Limitations
The studies on the cardiovascular effects of PPAR agonists have limitations such as small sample sizes and short trial durations.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website